182 related articles for article (PubMed ID: 2838948)
1. Activation of natural killer cells in newborn piglets by interferon induction.
Lesnick CE; Derbyshire JB
Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
[TBL] [Abstract][Full Text] [Related]
2. Hyporeactivity to interferon induction in newborn piglets.
Derbyshire JB; Lesnick CE
J Interferon Res; 1990 Feb; 10(1):47-53. PubMed ID: 1691769
[TBL] [Abstract][Full Text] [Related]
3. The effect of interferon induction in newborn piglets on the humoral immune response to oral vaccination with transmissible gastroenteritis virus.
Derbyshire JB; Lesnick CE
Vet Immunol Immunopathol; 1990 Mar; 24(3):227-34. PubMed ID: 1692649
[TBL] [Abstract][Full Text] [Related]
4. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
5. The effect of interferon induction in parturient sows and newborn piglets on resistance to transmissible gastroenteritis.
Loewen KG; Derbyshire JB
Can J Vet Res; 1988 Jan; 52(1):149-53. PubMed ID: 2450628
[TBL] [Abstract][Full Text] [Related]
6. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
[TBL] [Abstract][Full Text] [Related]
7. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
[TBL] [Abstract][Full Text] [Related]
9. The kinetics of interferon induction by poly ICLC in humans.
Bever CT; McFarland HF; McFarlin DE; Levy HB
J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
[TBL] [Abstract][Full Text] [Related]
10. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
Wild JS; Hyde DM; Giri SN
Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
[TBL] [Abstract][Full Text] [Related]
11. Increase in liver-associated natural killer activity by polyribonucleotides.
Twilley TA; Mason L; Talmadge JE; Wiltrout RH
Nat Immun Cell Growth Regul; 1987; 6(6):279-90. PubMed ID: 3448488
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of natural killer activity by polyribonucleotides.
Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
[TBL] [Abstract][Full Text] [Related]
13. Novel antiviral therapeutics to control foot-and-mouth disease.
Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
[TBL] [Abstract][Full Text] [Related]
14. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
[TBL] [Abstract][Full Text] [Related]
15. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
16. Biological characterization of MVE-2 and poly ICLC.
Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
[No Abstract] [Full Text] [Related]
17. Antiviral activity of interferon against transmissible gastroenteritis virus in cell culture and ligated intestinal segments in neonatal pigs.
Jordan LT; Derbyshire JB
Vet Microbiol; 1994 Jan; 38(3):263-76. PubMed ID: 8017030
[TBL] [Abstract][Full Text] [Related]
18. The role of interferon in spontaneous cell-mediated cytotoxicity in pigs.
Cepica A; Derbyshire JB
Vet Microbiol; 1986 Feb; 11(1-2):69-77. PubMed ID: 2422808
[TBL] [Abstract][Full Text] [Related]
19. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
Stringfellow DA; Weed SD
Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
[TBL] [Abstract][Full Text] [Related]
20. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
